Larissa Kruger Gomes, MD
Nephrology · East Providence, RINPI 1275914509
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,051 of the $4,215 with a category attached, or 72.4%. Alnylam Pharmaceuticals Inc. accounts for 60.6% of it on its own, with 5 other manufacturers making up the rest.
Across 33 payments — averaging $127.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alnylam Pharmaceuticals Inc.$3K
- AstraZeneca$1K
- Amgen$202
- Akebia Therapeutics Inc$173
- Calliditas Therapeutics US Inc.$31
- Travere Therapeutics, Inc.$26
Across 49 payments — averaging $46,586 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$887K
- AstraZeneca$690K
- Boehringer Ingelheim Pharma GmbH & Co.kg$260K
- Boehringer Ingelheim International GmbH$238K
- Vertex$170K
- Alnylam Pharmaceuticals Inc.$27K
- plus $10K from 1 others
What the payments were for
- Travel & lodging$3,05172%
- Food & beverage$1,14627%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 11 | $2,555 |
| AstraZeneca | 11 | $1,228 |
| Amgen | 4 | $202 |
| Akebia Therapeutics Inc | 3 | $173 |
| Calliditas Therapeutics US Inc. | 1 | $31 |
| Travere Therapeutics, Inc. | 3 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vafseo$122
How this compares
$4,215 in reported general payments places this provider in the 75th percentile of 45 nephrology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 86 | $99,482 |
| FarxigaDapagliflozin Propanediol | 35 | $31,006 |
| Clonidine | 12 | $2,873 |
| Losartan Potassium | 110 | $1,526 |
| Torsemide | 65 | $1,387 |
| Bumetanide | 55 | $1,261 |
| Cinacalcet Hcl | 17 | $1,042 |
| Amlodipine Besylate | 126 | $899 |
| Lisinopril | 114 | $897 |
| Olmesartan Medoxomil | 14 | $639 |
| Calcium Acetate | 13 | $599 |
| Calcitriol | 20 | $574 |
| Amiloride Hcl | 16 | $450 |
| Spironolactone | 44 | $435 |
| Metolazone | 18 | $381 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $1,228 | $31,00635 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 45 nephrology providers in Rhode Island.
Other nephrology in East Providence
- Manini VishwanathEast Providence$436
- Prerna GanjooEast Providence$309
- Daniel DragomireEast Providence$278
- Michael ThursbyEast Providence$249
- Christopher CosgroveEast Providence$136
- George LeeEast Providence$95
- Perola LambaEast Providence$48
- Mordecai StolkEast Providence$29
- Charles McCoyEast Providence$28
- Michael MonsourEast Providence$4
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.